516 related articles for article (PubMed ID: 16371011)
1. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
2. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
3. Single molecule profiling of tau gene expression in Alzheimer's disease.
Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
[TBL] [Abstract][Full Text] [Related]
4. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
Boutajangout A; Boom A; Leroy K; Brion JP
FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
[TBL] [Abstract][Full Text] [Related]
5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
7. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.
Stoilov P; Daoud R; Nayler O; Stamm S
Hum Mol Genet; 2004 Mar; 13(5):509-24. PubMed ID: 14709600
[TBL] [Abstract][Full Text] [Related]
8. Novel isoforms of tau that lack the microtubule-binding domain.
Luo MH; Tse SW; Memmott J; Andreadis A
J Neurochem; 2004 Jul; 90(2):340-51. PubMed ID: 15228591
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
[TBL] [Abstract][Full Text] [Related]
10. Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points.
Wang J; Tse SW; Andreadis A
J Neurochem; 2007 Jan; 100(2):437-45. PubMed ID: 17144905
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of amino-terminal Tau mRNA in rat spinal cord during development and following axonal injury.
Halverson RA; Chambers CB; Muma NA
Exp Neurol; 2001 May; 169(1):105-13. PubMed ID: 11312563
[TBL] [Abstract][Full Text] [Related]
12. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
[TBL] [Abstract][Full Text] [Related]
13. Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex.
Smith MJ; Sharples RA; Evin G; McLean CA; Dean B; Pavey G; Fantino E; Cotton RG; Imaizumi K; Masters CL; Cappai R; Culvenor JG
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):128-35. PubMed ID: 15306129
[TBL] [Abstract][Full Text] [Related]
14. Exon 3 insert of tau protein in neurodegenerative diseases.
Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
[TBL] [Abstract][Full Text] [Related]
15. The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.
van Swieten JC; Bronner IF; Azmani A; Severijnen LA; Kamphorst W; Ravid R; Rizzu P; Willemsen R; Heutink P
J Neuropathol Exp Neurol; 2007 Jan; 66(1):17-25. PubMed ID: 17204933
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10.
Gu J; Shi J; Wu S; Jin N; Qian W; Zhou J; Iqbal IG; Iqbal K; Gong CX; Liu F
FEBS Lett; 2012 Jul; 586(16):2239-44. PubMed ID: 22677170
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
[TBL] [Abstract][Full Text] [Related]
18. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
Leroy O; Dhaenens CM; Schraen-Maschke S; Belarbi K; Delacourte A; Andreadis A; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
J Neurosci Res; 2006 Sep; 84(4):852-9. PubMed ID: 16862542
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein E2 binds to tau exon 10 and moderately activates its splicing.
Broderick J; Wang J; Andreadis A
Gene; 2004 Apr; 331():107-14. PubMed ID: 15094196
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
